» Articles » PMID: 28616518

Relationship Between Electrocardiographic Findings and Cardiac Magnetic Resonance Phenotypes in Patients with Hypertrophic Cardiomyopathy

Overview
Date 2017 Jun 16
PMID 28616518
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Q waves and negative T waves are common electrocardiographic (ECG) abnormalities in patients with Hypertrophic Cardiomyopathy (HCM). Several studies correlated ECG findings with presence and extent of fibrosis and hypertrophy; however, their significance remains incompletely clarified. Our study aimed to explain the mechanism behind Q and negative T waves by comparing their positions on a 12-lead ECG with phenotypes observed at Late Gadolinium Enhancement (LGE) Cardiac Magnetic Resonance (CMR).

Methods: 12-lead ECG and LGE-CMR were performed in 88 consecutive patients with HCM (42 SD 16 years, 65 males). Using Delta Thickness ratio (DT ratio), and "global" and "parietal" LGE at CMR, the extent and distribution of myocardial hypertrophy and fibrosis were studied in correlation with ECG abnormalities.

Results: Q waves in different leads were not associated with "parietal" LGE score. Lateral Q waves correlated with an increased DT ratio Inferior Septum/Lateral wall ( = 0.01). A similar correlation between inferior Q waves and an increased DT Ratio Anterior wall/Inferior wall was of borderline statistical significance ( = 0.06). As expected, ECG signs of LV hypertrophy related to a raised Left Ventricular Mass Index (LVMI) ( < 0.0001) and mean wall thickness ( = 0.01). Depolarization disturbances, including negative T waves in lateral ( = 0.044) and anterior ( = 0.031) leads correlated with "parietal" LGE scores while QT dispersion ( = 0.0001) was associated with "global" LGE score.

Conclusion: In HCM patients, Q waves are generated by asymmetric hypertrophy rather than by myocardial fibrosis, while negative T waves result from local LGE distribution at CMR.

Citing Articles

Mobile Electrocardiograms in the Detection of Subclinical Atrial Fibrillation in High-Risk Outpatient Populations: Protocol for an Observational Study.

Mittal A, Elkaldi Y, Shih S, Nathu R, Segal M JMIR Res Protoc. 2024; 13:e52647.

PMID: 38801762 PMC: 11165282. DOI: 10.2196/52647.


Electrocardiographic and genetic characteristics in first degree relatives of hypertrophic cardiomyopathy probands: A descriptive cross-sectional study from Vietnam.

Phan P, Tran V, Pham M, Mai A, An D, Pham H JRSM Cardiovasc Dis. 2024; 13:20480040231220100.

PMID: 38186735 PMC: 10768582. DOI: 10.1177/20480040231220100.


Association of electrocardiographic markers with myocardial fibrosis as assessed by cardiac magnetic resonance in different clinical settings.

Bazoukis G, Garcia-Zamora S, Cinier G, Lee S, Gul E, Alvarez-Garcia J World J Cardiol. 2022; 14(9):483-495.

PMID: 36187429 PMC: 9523270. DOI: 10.4330/wjc.v14.i9.483.


Electro- and echocardiographic features of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy.

Bula K, Bisaga J, Feret B, Razik M, Rozpiatkowska B, Tometczak M Ann Noninvasive Electrocardiol. 2022; 27(5):e12992.

PMID: 35855565 PMC: 9484024. DOI: 10.1111/anec.12992.


Deciphering hypertrophic cardiomyopathy with electrocardiography.

Gossios T, Savvatis K, Zegkos T, Ntelios D, Rouskas P, Parcharidou D Heart Fail Rev. 2021; 27(4):1313-1323.

PMID: 34286451 DOI: 10.1007/s10741-021-10147-0.


References
1.
Hansen M, Merchant N . MRI of hypertrophic cardiomyopathy: part I, MRI appearances. AJR Am J Roentgenol. 2007; 189(6):1335-43. DOI: 10.2214/AJR.07.2286. View

2.
Song B, Yang H, Hwang H, Kang G, Park Y, Chun W . Correlation of electrocardiographic changes and myocardial fibrosis in patients with hypertrophic cardiomyopathy detected by cardiac magnetic resonance imaging. Clin Cardiol. 2012; 36(1):31-5. PMC: 6649432. DOI: 10.1002/clc.22062. View

3.
Thygesen K, Alpert J, White H, Jaffe A, Katus H, Apple F . Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012; 60(16):1581-98. DOI: 10.1016/j.jacc.2012.08.001. View

4.
Rickers C, Wilke N, Jerosch-Herold M, Casey S, Panse P, Panse N . Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005; 112(6):855-61. DOI: 10.1161/CIRCULATIONAHA.104.507723. View

5.
Alfonso F, Nihoyannopoulos P, Stewart J, Dickie S, Lemery R, McKenna W . Clinical significance of giant negative T waves in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1990; 15(5):965-71. DOI: 10.1016/0735-1097(90)90225-e. View